logo
Are Allergy Shots Worth It?

Are Allergy Shots Worth It?

Nearly a third of American adults have some kind of allergy. If you're one of them, you're probably eager to find a solution.
Allergy shots can provide long-lasting relief for certain non-food allergies, but there are some downsides. Is the time commitment, discomfort, and cost worth it?
To help make that decision, here's the latest science behind allergy immunotherapy, how long the effects of the shots last, and what the future of allergy shots may hold.
How do allergy shots work?
Allergy shots have been around in one form or another since the 1910s. The idea is to desensitize an allergic person to a specific allergen, like pollen or cat dander.
Your allergist will determine exactly what you're allergic to and then 'they make a specialized cocktail of allergens for that person,' says Dr. David Morris, chief of allergy and immunology at Dayton Children's Hospital. This cocktail contains very small, diluted amounts of those allergens and is then injected under your skin.
'This stimulates the immune system to feel like these things are normal and not foreign,' says allergist Dr. J. Allen Meadows, executive director of advocacy and governmental affairs at the American College of Allergy, Asthma & Immunology (ACAAI) and a pediatric allergist at the University of Alabama at Birmingham.
After your shot, you'll be observed for about 30 minutes. 'This is because you do have the potential to have a reaction; we're giving you something injectable that you're allergic to,' Morris says. Serious reactions are rare but can be life-threatening, according to the American Academy of Allergy, Asthma, and Immunology (AAAAI).
For the next several months, you'll get one or two shots a week containing increasing amounts of your allergens. This process helps you slowly build a tolerance to those allergens, Meadows says.
After about seven months, your doctor will be able to space out your doses to every two weeks. Eventually, you get to what's considered a maintenance dose, which is when you can move to 'a shot a month at a high dose of what you're allergic to,' says otolaryngologist Dr. Marc Dubin, chief medical officer at ENT Speciality Partners.
You'll likely stick to that once-a-month shot for three to five years. It can take as long as 12 months on your maintenance dose before you notice your symptoms are improving. In other words, allergy shots are definitely a time commitment.
If you can make the time, however, then comes the payoff: 'It changes your immune system on a long-term basis,' Meadows says. You don't have to take any more shots, and you're free of your allergy symptoms—often for decades, he says. 'Some allergists will say the results last 'forever,' but forever is a long time, so I'm not as comfortable with that.'
Who gets the best results?
Anyone older than 5 can benefit from allergy shots, according to the AAAAI. People with pollen allergies tend to really appreciate the treatment effects, Morris says. 'For a patient's quality of life, pollen is the [most] noticeable one, because people are miserable during pollen season, and they notice they're no longer miserable,' he says.
But if your symptoms are severe to start with, you might not see as much relief, Dubin says. You shouldn't get allergy shots if you currently have severe asthma symptoms, or if you're taking certain medications, including beta-blockers for high blood pressure and certain antidepressants, he adds.
Allergy shots can also be used for people who are allergic to insect stings, but the process often takes longer and comes with more risks, Dubin says.
If your symptoms start to come back after a course of allergy shots, you can go for another round. In fact, that's quite common in Morris' practice, considering he treats children: They might complete allergy shots in childhood and repeat the process in their 30s, he says.
How much do allergy shots cost?
Insurance coverage varies from person to person, but most people can expect to have some out-of-pocket costs for allergy shots—anywhere from $1,000 to $4,000 for office-visit copays and the treatment itself, Morris says.
'I have seen some of the insurers charge a copay for every shot,' Morris says. 'So if you're getting 28 shots—one a week for six months—and you've got a $25 copay, you start to do the math.' The cost alone can make allergy shots unrealistic for some people.
What advancements are in the pipeline?
Some health care providers are using shorter timelines for administering allergy shots, sometimes referred to as rapid desensitization or cluster or rush immunotherapy.
Instead of getting one shot a week during your build-up phase, you might get several shots a week—even more than one shot in a day, Morris says. This expedites the time it takes to reach the maintenance phase to a few weeks or months. However, people generally have a higher risk of having a reaction on a faster allergy shot schedule, he adds.
There is also a tablet form of allergen immunotherapy that works for people who are allergic to ragweed, some grasses, and dust. You let the tablet dissolve under your tongue at least three days a week. While under-the-tongue tablets and drops have been popular in Europe for some time, this method hasn't really caught on in the U.S., where most insurance providers don't cover it without prior authorization, Meadows says.
While the tablets can make your mouth itchy, the risk of serious side effects is low. So another plus of this technique is you can do it yourself at home without needing to be monitored by your doctor, Dubin says.
Although it's still in early research phases, Morris is intrigued by a new technique involving injecting allergens into a lymph node, where immune cells live, rather than under the skin, called intralymphatic immunotherapy.
This approach kicks in quickly: It takes just three injections over two months. However, it requires an ultrasound to deliver the shot, so it takes some technical skill and the right equipment, he says. It's currently available at a limited number of health care facilities, but it's not yet approved by the U.S. Food and Drug Administration.
'Not all these are going to be right for every patient, [but] I'm excited for patients to get some quality-of-life improvements,' Morris says. 'I recommend people see a board-certified allergist and discuss these treatments and the risks and benefits and decide what's right for them.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New National Poll Finds Overwhelming Majorities of Voters Want 'America First' Reforms of Big Pharma's Business Practices, Want to Limit Direct-to-Consumer Pharmaceutical Advertising, & Support President Trump's Executive Order on Drug Pricing
New National Poll Finds Overwhelming Majorities of Voters Want 'America First' Reforms of Big Pharma's Business Practices, Want to Limit Direct-to-Consumer Pharmaceutical Advertising, & Support President Trump's Executive Order on Drug Pricing

Associated Press

timean hour ago

  • Associated Press

New National Poll Finds Overwhelming Majorities of Voters Want 'America First' Reforms of Big Pharma's Business Practices, Want to Limit Direct-to-Consumer Pharmaceutical Advertising, & Support President Trump's Executive Order on Drug Pricing

WASHINGTON--(BUSINESS WIRE)--Jun 11, 2025-- Today, the Pharmaceutical Reform Alliance (PRA) announced the results of a nationally representative poll of American voters, who overwhelmingly agree that it's time to rein in Big Pharma, hold them accountable for soaring prescription drug costs, and implement commonsense reforms that make prescription drugs more affordable and more accessible for Americans. The poll was conducted by Republican polling firm National Research, and its President, Adam Geller, who is also a pollster for Preserve America, President Trump's SuperPAC. The poll, conducted among 1,000 registered voters across the United States from May 28-June 1, 2025, found significant consensus among substantial majorities of American voters from across the political spectrum. The poll's key findings include: Majorities of voters have difficulty paying for rising prescription medications and blame 'Big Pharma.' American voters want 'America First' reforms to lower prices and support President Trump's Executive Order. American voters support significant reforms of Big Pharma's Direct-to-Consumer Advertising. Overwhelmingly, American voters support additional reforms of Big Pharma's business practices. Electorally, American voters would support congressional candidates who are anti-Big Pharma. Commenting on the poll's findings, Pharmaceutical Reform Alliance spokesman and former U.S. Representative J.D. Hayworth (R-AZ) said, 'Americans are speaking loudly and clearly, so it's important for Congress to listen: the time to join President Trump in lowering prescription drug costs is NOW. From coast to coast, the American people are suffering from high prescription costs, and they rightly blame Big Pharma. Simply stated, it's time for Big Pharma to put America first…not last. As a former member of Congress, it's obvious that the results of this poll are clear and convincing. No doubt those currently serving on Capitol Hill are hearing the same message from their constituents. With the 2026 primary season ahead, those in the House and Senate need to take action. Voters are watching.' In short, American voters want reform now and can't afford to wait. Congress should follow the Trump administration's lead and abide by the will of the people. It can do so by bringing down the cost of drugs, holding Big Pharma accountable for its anti-competitive tactics, and demanding transparency in order to protect Americans from Big Pharma's misleading marketing practices. 'In case it wasn't clear before, it's clear now,' added pollster Adam Geller. 'American voters are telling us they want 'America First' reforms and that they will vote for congressional candidates who follow President Trump's lead and who will push for these reforms. Based on our poll, anyone running for Congress, and especially those looking to court MAGA Republican voters, would be wise to advocate for these reforms.' A memorandum of the polling results can be found at Adam Geller, President, has played a role in every single Trump presidential campaign. In 2016, Adam was one of the pollsters for the Trump presidential campaign, where he conducted polling and ad testing in the Blue Wall states of Michigan, Wisconsin, Iowa, and Pennsylvania. In 2020, Adam worked with Chris LaCivita on the Trump-aligned SuperPAC, Preserve America. And, in 2024, Adam continued his work on the Trump-aligned Preserve America SuperPAC. View source version on CONTACT: Media Contact: Rick VanMeter 859.333.0149 [email protected] KEYWORD: UNITED STATES NORTH AMERICA DISTRICT OF COLUMBIA INDUSTRY KEYWORD: PUBLIC POLICY/GOVERNMENT HEALTHCARE REFORM PHARMACEUTICAL HEALTH SOURCE: Pharmaceutical Reform Alliance Copyright Business Wire 2025. PUB: 06/11/2025 08:15 AM/DISC: 06/11/2025 08:15 AM

New National Poll Finds Overwhelming Majorities of Voters Want 'America First' Reforms of Big Pharma's Business Practices, Want to Limit Direct-to-Consumer Pharmaceutical Advertising, & Support President Trump's Executive Order on Drug Pricing
New National Poll Finds Overwhelming Majorities of Voters Want 'America First' Reforms of Big Pharma's Business Practices, Want to Limit Direct-to-Consumer Pharmaceutical Advertising, & Support President Trump's Executive Order on Drug Pricing

Business Wire

timean hour ago

  • Business Wire

New National Poll Finds Overwhelming Majorities of Voters Want 'America First' Reforms of Big Pharma's Business Practices, Want to Limit Direct-to-Consumer Pharmaceutical Advertising, & Support President Trump's Executive Order on Drug Pricing

WASHINGTON--(BUSINESS WIRE)--Today, the Pharmaceutical Reform Alliance (PRA) announced the results of a nationally representative poll of American voters, who overwhelmingly agree that it's time to rein in Big Pharma, hold them accountable for soaring prescription drug costs, and implement commonsense reforms that make prescription drugs more affordable and more accessible for Americans. The poll was conducted by Republican polling firm National Research, and its President, Adam Geller, who is also a pollster for Preserve America, President Trump's SuperPAC. The poll, conducted among 1,000 registered voters across the United States from May 28-June 1, 2025, found significant consensus among substantial majorities of American voters from across the political spectrum. The poll's key findings include: Majorities of voters have difficulty paying for rising prescription medications and blame 'Big Pharma.' 86% say they or someone in their household 'take(s) prescription medications.' 85% say 'prescription medication prices in the United States have been getting…more expensive.' 51% say they or someone in their household has had 'difficulty affording prescription medications.' 63% say 'NO' when asked, 'Do you feel the price you pay for prescription medications is fair?' 81% AGREE 'Big Pharma raises medication prices every year, ripping off American families.' 67% say 'YES' when asked, 'Do you personally feel that you've been taken advantage of by Big Pharma, in terms of paying high costs for medicines you or a family member need?' 79% say they hold an 'unfavorable' opinion of the pharmaceutical industry (43% 'very unfavorable'). 84% say they hold the pharmaceutical industry 'most responsible for the high cost of prescription medications.' American voters want 'America First' reforms to lower prices and support President Trump's Executive Order. 77% say it is a critical (35% critical) or high (42%) priority to 'reduce prescription medication prices in the United States.' 94% SUPPORT 'reform efforts to reduce the price of prescription medication in the United States.' 85% SUPPORT ''America First' pharmaceutical reforms so that the cost for prescription medications for American patients matches the costs in countries with the lowest prices.' 96% AGREE (82% strongly agree) that 'prescription medications that are developed with your tax dollars should be provided at a low cost to Americans.' 78% SUPPORT President Trump's May 12 th 'Delivering Most-Favored Nation Prescription Drug Pricing to American Patients' Executive Order. Notably, 61% of Democrats and 59% of Harris voters SUPPORT the President's Executive Order. American voters support significant reforms of Big Pharma's Direct-to-Consumer Advertising. 89% SUPPORT 'requiring pharmaceutical companies to disclose the price of the medicine in any direct-to-consumer advertising they do.' 79% SUPPORT 'eliminating tax breaks for medication companies' direct-to-consumer advertising expenses.' 75% SUPPORT 'restricting direct-to-consumer prescription medication ads — like those on TV — that provide news networks with big advertising profits and may skew or bias their news coverage on Big Pharma.' 74% SUPPORT 'restricting direct-to-consumer prescription medication ads — like those on TV — that often result in people asking their doctors for prescriptions they may not need or may not be suited for their conditions.' 66% SUPPORT 'Health & Human Services (HHS) Secretary Robert F. Kennedy Jr. and the MAHA Commission's proposal to limit direct-to-consumer pharmaceutical advertising.' Overwhelmingly, American voters support additional reforms of Big Pharma's business practices. 90% AGREE 'congressional candidates should stop taking large political donations from Big Pharma because it is a conflict of interest.' 85% SUPPORT 'revising the patent process for prescription medications in order to bring less expensive generic versions of the same medication to market faster.' Electorally, American voters would support congressional candidates who are anti-Big Pharma. 86% would be MORE LIKELY TO SUPPORT 'a congressional candidate who wants to force Big Pharma to lower prescription medication costs for American consumers.' Notably, 94% of MAGA Republicans would be MORE LIKELY TO SUPPORT versus 72% of Traditional Republicans. 78% would be LESS LIKELY TO SUPPORT 'a congressional candidate who takes donations from Big Pharma.' Notably, 86% of MAGA Republicans would be LESS LIKELY TO SUPPORT versus 63% of Traditional Republicans. 77% would be MORE LIKELY SUPPORT 'a congressional candidate who wants to restrict the amount of advertising that Big Pharma can buy on news networks that are supposed to produce impartial, unbiased journalism and news.' Notably, 90% of MAGA Republicans would be MORE LIKELY TO SUPPORT versus 65% of Traditional Republicans. Commenting on the poll's findings, Pharmaceutical Reform Alliance spokesman and former U.S. Representative J.D. Hayworth (R-AZ) said, 'Americans are speaking loudly and clearly, so it's important for Congress to listen: the time to join President Trump in lowering prescription drug costs is NOW. From coast to coast, the American people are suffering from high prescription costs, and they rightly blame Big Pharma. Simply stated, it's time for Big Pharma to put America first…not last. As a former member of Congress, it's obvious that the results of this poll are clear and convincing. No doubt those currently serving on Capitol Hill are hearing the same message from their constituents. With the 2026 primary season ahead, those in the House and Senate need to take action. Voters are watching." In short, American voters want reform now and can't afford to wait. Congress should follow the Trump administration's lead and abide by the will of the people. It can do so by bringing down the cost of drugs, holding Big Pharma accountable for its anti-competitive tactics, and demanding transparency in order to protect Americans from Big Pharma's misleading marketing practices. 'In case it wasn't clear before, it's clear now,' added pollster Adam Geller. 'American voters are telling us they want 'America First' reforms and that they will vote for congressional candidates who follow President Trump's lead and who will push for these reforms. Based on our poll, anyone running for Congress, and especially those looking to court MAGA Republican voters, would be wise to advocate for these reforms.' A memorandum of the polling results can be found at About The Poll National Research Inc. conducted the poll of 1,000 registered voters across the United States on May 28-June 1, 2025. The margin of error for the survey is +/- 3.1% at the 95% confidence interval. The mode of data collection was via SMS to web. The sample source was a listed voter file of registered voters, including those who are newly registered. Individual voter demographics, like geography, gender, age, race, partisan affiliation, and education were matched to the voter file and past voter turnout. About The Pharmaceutical Reform Alliance (PRA) The Pharmaceutical Reform Alliances (PRA) is a national 501c4 organization committed to growing awareness about Big Pharma's anti-consumer practices that are resulting in skyrocketing prices in the United States for a wide range of vital pharmaceutical drugs. For more information, visit About National Research and Adam Geller National Research Inc. is a New Jersey-based national survey research company. National Research consistently receives one of the highest grades for accuracy in 538's national ranking of pollsters, and over the course of 23 years, National Research has conducted hundreds of thousands of interviews for political campaigns, public relations clients, advertising agencies, and Fortune 500 corporations. Adam Geller, President, has played a role in every single Trump presidential campaign. In 2016, Adam was one of the pollsters for the Trump presidential campaign, where he conducted polling and ad testing in the Blue Wall states of Michigan, Wisconsin, Iowa, and Pennsylvania. In 2020, Adam worked with Chris LaCivita on the Trump-aligned SuperPAC, Preserve America. And, in 2024, Adam continued his work on the Trump-aligned Preserve America SuperPAC.

Most voters in favor of Trump's ‘most favored nation' drug price policy: survey
Most voters in favor of Trump's ‘most favored nation' drug price policy: survey

Yahoo

time2 hours ago

  • Yahoo

Most voters in favor of Trump's ‘most favored nation' drug price policy: survey

A new survey found that a majority of voters are in favor lawmakers and candidates who they believe will take on Big Pharma price-gouging with most saying they're in favor of President Trump's 'most favored nation' policy. In a survey commissioned by the Pharmaceutical Reform Alliance and conducted by National Research Inc., 85 percent of voters said prescription medications have gotten more expensive and nearly the same percentage of participants said pharmaceutical companies carried the most blame for the high cost. When asked about their voting choices, 86 percent said they were more likely to support a candidate who 'wants to force Big Pharma to lower prescription medication costs for American consumers' while 78 percent said they were less likely to support a candidate who accepted donations from Big Pharma. Overall, 90 percent of participants agreed with this statement: 'Congressional candidates should stop taking large political donations from Big Pharma because it is a conflict of interest.' During the 2024 election cycle, pharmaceutical and health product political action committees donated over $16 million to campaigns. 'Americans are speaking loudly and clearly, so it's important for Congress to listen: the time to join President Trump in lowering prescription drug costs is NOW. From coast to coast, the American people are suffering from high prescription costs, and they rightly blame Big Pharma. Simply stated, it's time for Big Pharma to put America first…not last,' PRA spokesman and former Rep. J.D. Hayworth (R-Ariz.) said in a statement. 'No doubt those currently serving on Capitol Hill are hearing the same message from their constituents. With the 2026 primary season ahead, those in the House and Senate need to take action. Voters are watching,' he added. The survey highlighted Trump's executive order that enacted 'most favored nation' drug pricing as an example of efforts to reduce prescription drug costs. The executive order directs the Department of Commerce and the U.S. Trade Representative Jamieson Greer to take 'all appropriate action' against 'unreasonable and discriminatory' policies in foreign countries that suppress drug prices abroad. Health and Human Services Secretary Robert F. Kennedy Jr. will set 'clear targets' for prescription drug and pharmaceutical price reductions within 30 days per the order. When asked about how they felt regarding the 'most favored nation' policy, 78 percent said they supported the policy, which included 61 percent of Democrats, 77 percent of independent voters and 96 percent of Republicans. Republican participants were asked to pick between Trump; Kennedy and his 'make American health again' agenda; or Congress when it came to whom they trusted to 'force Big Pharma to lower their costs for prescription medicine.' Trump received the highest vote of confidence with 46 percent of GOP voters picking him, 14 percent picked Kennedy and only two percent picked Congress. Other changes that garnered support in the survey were restrictions on direct-to-consumer prescription medication ads and 78 percent agreed it was a conflict of interest for news networks to run such ads as they're covering health care issues. The survey was conducted from May 28 to June 1 and included 1,000 registered voters. The results have a margin or error of plus or minus 3.1 percentage points at the 95 percent confidence interval. Among participants, 35 percent were Republican, 33 percent were Democrat and 32 percent were independent. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store